|
Volumn 86, Issue 2, 2001, Pages 187-191
|
Primary mediastinal large B-cell lymphoma with sclerosis: A clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy
a a a a a a a a a a a a a |
Author keywords
MACOP B regimen; PMLBCL with sclerosis; Radiation therapy; Relapse free survival
|
Indexed keywords
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
ARTICLE;
B CELL LYMPHOMA;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL FEATURE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDIASTINUM;
PATIENT SELECTION;
SCLEROSIS;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
LEUCOVORIN;
LYMPHOMA, B-CELL;
LYMPHOMA, LARGE-CELL;
MALE;
MEDIASTINAL NEOPLASMS;
METHOTREXATE;
MIDDLE AGED;
PREDNISONE;
SCLEROSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 20244370498
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (67)
|
References (24)
|